Prevalence of Severe Depression in Iranian Women with Breast Cancer: A Meta-Analysis.

Q1 Psychology

Depression Research and Treatment Pub Date : 2020-05-12 eCollection Date: 2020-01-01 DOI:10.1155/2020/5871402

Parvaneh Isfahani, Marziye Arefy, Monire Shamsaii

{"title":"Prevalence of Severe Depression in Iranian Women with Breast Cancer: A Meta-Analysis.","authors":"Parvaneh Isfahani, Marziye Arefy, Monire Shamsaii","doi":"10.1155/2020/5871402","DOIUrl":null,"url":null,"abstract":"Background: Breast cancer is one of the most common cancers in women and has mental and emotional effects, which lead to a decline in their quality of life. This study is aimed at determining the prevalence of severe depression in Iranian women with breast cancer.Methods: This meta-analysis study was conducted at Zabol University of Medical Sciences in 2019. Seven electronic databases were searched and evaluated for original research papers published on the prevalence of severe depression in Iranian women with breast cancer. Finally, 13 articles were selected and analyzed via Comprehensive Meta-Analysis software.Results: Overall, the prevalence of severe depression in Iranian women with breast cancer was 11% (95% CI (7.2, 16.5)). The highest prevalence was 44% in Tehran City in 2015 (95% CI (31, 57.9)), and the lowest prevalence was 0.8% in Qom City in 2017 (95% CI (0.01, 6.2)). A significant statistical correlation was observed between the prevalence of severe depression and sample size (p < 0.05).Conclusion: According to the results of this study, the prevalence of severe depression affects more than one-tenth of women with breast cancer.","PeriodicalId":38441,"journal":{"name":"Depression Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/5871402","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Depression Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/5871402","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Psychology","Score":null,"Total":0}

引用次数: 12

Abstract

Background: Breast cancer is one of the most common cancers in women and has mental and emotional effects, which lead to a decline in their quality of life. This study is aimed at determining the prevalence of severe depression in Iranian women with breast cancer.

Methods: This meta-analysis study was conducted at Zabol University of Medical Sciences in 2019. Seven electronic databases were searched and evaluated for original research papers published on the prevalence of severe depression in Iranian women with breast cancer. Finally, 13 articles were selected and analyzed via Comprehensive Meta-Analysis software.

Results: Overall, the prevalence of severe depression in Iranian women with breast cancer was 11% (95% CI (7.2, 16.5)). The highest prevalence was 44% in Tehran City in 2015 (95% CI (31, 57.9)), and the lowest prevalence was 0.8% in Qom City in 2017 (95% CI (0.01, 6.2)). A significant statistical correlation was observed between the prevalence of severe depression and sample size (p < 0.05).

Conclusion: According to the results of this study, the prevalence of severe depression affects more than one-tenth of women with breast cancer.

Abstract Image

查看原文本刊更多论文

伊朗女性乳腺癌患者重度抑郁症患病率:一项荟萃分析

背景:乳腺癌是女性中最常见的癌症之一，具有精神和情感上的影响，导致她们的生活质量下降。本研究旨在确定伊朗乳腺癌妇女严重抑郁症的患病率。方法:本荟萃分析研究于2019年在Zabol医学科学大学进行。对七个电子数据库进行了检索和评估，以获取发表的关于伊朗乳腺癌妇女严重抑郁症患病率的原始研究论文。最后选取13篇文章，通过综合meta分析软件进行分析。结果:总体而言，伊朗女性乳腺癌患者中重度抑郁症的患病率为11% (95% CI(7.2, 16.5))。2015年，德黑兰市的患病率最高，为44% (95% CI(31,57.9))， 2017年库姆市的患病率最低，为0.8% (95% CI(0.01, 6.2))。重度抑郁症患病率与样本量有显著的统计学相关性(p < 0.05)。结论:根据这项研究的结果，超过十分之一的乳腺癌女性患有严重的抑郁症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Depression Research and Treatment Psychology-Clinical Psychology

CiteScore

8.80

自引率

0.00%

发文量

审稿时长

10 weeks